FREENOME LIMITED
MEDICITY - D6 BUILDING, 1 THANE ROAD, NOTTINGHAM  NG90 6BH- Active
- Private Limited Company
- Company No. 04606727
- Last Updated: 01 Mar 2024
Company Profile
FREENOME LIMITED was incorporated on Tuesday, December 3, 2002 as a Private Limited Company with registered address in NOTTINGHAM. FREENOME LIMITED has the status: Active and it's listed in the following category: Manufacture of other chemical products n.e.c.. This Private Limited Company has been operating for 22 years 2 months and 20 days.
Name | FREENOME LIMITED |
---|---|
Company number | 04606727 |
Company type | Private Limited Company |
Incorporation date | 03 Dec 2002 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
MEDICITY - D6 BUILDING 1 THANE ROAD NOTTINGHAM NG90 6BH |
---|---|
Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Freenome Holdings, Inc 1209 Orange St, Wilmington, 19801 |
Dates: Friday, May 19, 2023 - Friday, May 19, 2023
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors
|
Oncimmune Holdings Plc Hucknall Road, NG5 1PB |
Dates: Wednesday, April 6, 2016 - Friday, May 19, 2023
ownership of shares 75 to 100 percent
ownership of shares 75 to 100 percent as firm
|
Accounts and Confirmation
Type of accounts | FULL |
---|---|
End of financial Year | 31 December |
Next annual accounts due | 30 September 2024, (-146 days left) |
Latest accounts | 31 August 2022 |
Next confirmation statement due | 31 December 2016 |
Last confirmation statement dated | 03 December 2015 |
Mortgages
Total of Mortgages | 3 |
---|---|
Mortgages Outstanding | 2 |
Mortgages Partially Satisfied | 0 |
Mortgages Satisfied/Paid | 1 |
Previous Names
Name | Change Date |
---|---|
FREENOME LIMITED | 03 Dec 2002 |
ONC-IMMUNE LIMITED | 14 Feb 2006 |
ONCIMMUNE LIMITED | 22 May 2023 |